CEFDALOXIME

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C14H15N5O6S2
Molecular Weight	413.429
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C3=CSC(N)=N3)C(O)=O

InChI

InChIKey=HOGISBSFFHDTRM-GHXIOONMSA-N

InChI=1S/C14H15N5O6S2/c1-25-2-5-3-26-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-27-14(15)16-6/h4,8,12,24H,2-3H2,1H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C14H15N5O6S2
Molecular Weight	413.429
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	1
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1478050 | https://www.ncbi.nlm.nih.gov/pubmed/1583135 | https://www.ncbi.nlm.nih.gov/pubmed/8150978

Cefdaloxime is a third-generation cephalosporin antibiotic patented by pharmaceutical company Roussel-UCLAF. Cefdaloxime activity was the poorest among the different oral cephalosporins.

Originator

Approval Year

PubMed

Title	Date	PubMed
Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.	1992 Nov-Dec	1478050

Patents

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:12:47 UTC 2023` Edited by `admin` on `Fri Dec 15 16:12:47 UTC 2023`
Record UNII	6856HDT30F
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CEFDALOXIME

Official Name

English

cefdaloxime [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C357